Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 1
2016 3
2017 5
2018 6
2019 10
2020 7
2021 5
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

29 results

Results by year

Filters applied: . Clear all
Page 1
Genetic factors contributing to late adverse musculoskeletal effects in childhood acute lymphoblastic leukemia survivors.
Shalmiev A, Nadeau G, Aaron M, Ouimet-Grennan E, Drouin S, Bertout L, Beaulieu P, St-Onge P, Veilleux LN, Rauch F, Rezgui A, Petrykey K, Laverdière C, Sinnett D, Alos N, Krajinovic M. Shalmiev A, et al. Among authors: bertout l. Pharmacogenomics J. 2022 Feb;22(1):19-24. doi: 10.1038/s41397-021-00252-6. Epub 2021 Aug 26. Pharmacogenomics J. 2022. PMID: 34446917
Genetic factors in treatment-related cardiovascular complications in survivors of childhood acute lymphoblastic leukemia.
Petrykey K, Rezgui AM, Guern ML, Beaulieu P, St-Onge P, Drouin S, Bertout L, Wang F, Baedke JL, Yasui Y, Hudson MM, Raboisson MJ, Laverdière C, Sinnett D, Andelfinger GU, Krajinovic M. Petrykey K, et al. Among authors: bertout l. Pharmacogenomics. 2021 Sep;22(14):885-901. doi: 10.2217/pgs-2021-0067. Epub 2021 Sep 10. Pharmacogenomics. 2021. PMID: 34505544 Free PMC article.
Contributing Factors of Unmet Needs Among Young Adult Survivors of Childhood Acute Lymphoblastic Leukemia with Comorbidities.
Lamore K, Bourdeau C, Alos N, Bertout L, Curnier D, Drouin S, Krajinovic M, Laverdière C, Lippé S, Marcil V, Robaey P, Rondeau É, Sinnett D, Sultan S. Lamore K, et al. Among authors: bertout l. J Adolesc Young Adult Oncol. 2021 Aug;10(4):462-475. doi: 10.1089/jayao.2020.0090. Epub 2020 Sep 14. J Adolesc Young Adult Oncol. 2021. PMID: 32924727
Physical Activity and Sedentary Behaviors in Childhood Acute Lymphoblastic Leukemia Survivors.
Lemay V, Caru M, Samoilenko M, Drouin S, Mathieu ME, Bertout L, Lefebvre G, Raboisson MJ, Krajinovic M, Laverdière C, Andelfinger G, Sinnett D, Curnier D. Lemay V, et al. Among authors: bertout l. J Pediatr Hematol Oncol. 2020 Jan;42(1):53-60. doi: 10.1097/MPH.0000000000001594. J Pediatr Hematol Oncol. 2020. PMID: 31568179 Clinical Trial.
Inconsistencies between measures of cognitive dysfunction in childhood acute lymphoblastic leukemia survivors: Description and understanding.
Leclerc AA, Lippé S, Bertout L, Chapados P, Boulet-Craig A, Drouin S, Krajinovic M, Laverdière C, Michon B, Robaey P, Rondeau É, Sinnett D, Sultan S. Leclerc AA, et al. Among authors: bertout l. Psychooncology. 2020 Jul;29(7):1201-1208. doi: 10.1002/pon.5410. Epub 2020 Jun 1. Psychooncology. 2020. PMID: 32391960
Identification of a single-nucleotide polymorphism within CDH2 gene associated with bone morbidity in childhood acute lymphoblastic leukemia survivors.
Aaron M, Nadeau G, Ouimet-Grennan E, Drouin S, Bertout L, Beaulieu P, St-Onge P, Shalmiev A, Veilleux LN, Rauch F, Petrykey K, Laverdière C, Sinnett D, Alos N, Krajinovic M. Aaron M, et al. Among authors: bertout l. Pharmacogenomics. 2019 Apr;20(6):409-420. doi: 10.2217/pgs-2018-0169. Epub 2019 Apr 15. Pharmacogenomics. 2019. PMID: 30983502
The PETALE study: Late adverse effects and biomarkers in childhood acute lymphoblastic leukemia survivors.
Marcoux S, Drouin S, Laverdière C, Alos N, Andelfinger GU, Bertout L, Curnier D, Friedrich MG, Kritikou EA, Lefebvre G, Levy E, Lippé S, Marcil V, Raboisson MJ, Rauch F, Robaey P, Samoilenko M, Séguin C, Sultan S, Krajinovic M, Sinnett D. Marcoux S, et al. Among authors: bertout l. Pediatr Blood Cancer. 2017 Jun;64(6). doi: 10.1002/pbc.26361. Epub 2016 Dec 4. Pediatr Blood Cancer. 2017. PMID: 27917589 Clinical Trial.
Polymorphisms of ABCC5 and NOS3 genes influence doxorubicin cardiotoxicity in survivors of childhood acute lymphoblastic leukemia.
Krajinovic M, Elbared J, Drouin S, Bertout L, Rezgui A, Ansari M, Raboisson MJ, Lipshultz SE, Silverman LB, Sallan SE, Neuberg DS, Kutok JL, Laverdière C, Sinnett D, Andelfinger G. Krajinovic M, et al. Among authors: bertout l. Pharmacogenomics J. 2017 Jan;17(1):107. doi: 10.1038/tpj.2016.86. Epub 2016 Dec 13. Pharmacogenomics J. 2017. PMID: 27958382 No abstract available.
29 results